Status:
COMPLETED
rSVO₂ and Postoperative Delirium Prediction
Lead Sponsor:
Wonkwang University Hospital
Conditions:
Delirium, Postoperative
Eligibility:
All Genders
65+ years
Brief Summary
This prospective observational cohort study will enroll 300 patients aged ≥65 years undergoing elective noncardiac, non-neurosurgical procedures . Baseline rSVO₂ will be measured preoperatively using ...
Detailed Description
Study Design and Population This prospective observational cohort study will be conducted at Wonkwang University School of Medicine Hospital from May 2025, upon approval by the Institutional Review Bo...
Eligibility Criteria
Inclusion
- Age ≥ 65 years Scheduled for elective noncardiac, non-neurosurgical surgery under general anesthesia Expected postoperative hospital stay ≥ 2 nights Able to provide informed consent Capable of completing preoperative frailty and cognitive assessments
Exclusion
- History of dementia, stroke, or cerebral tumors Chronic use of antipsychotic or anticholinergic medications Inability to complete cognitive assessments (e.g., language barrier, severe hearing/vision impairment) Current hemodialysis treatment Severe jaundice Missing baseline rSVO₂ data
Key Trial Info
Start Date :
April 29 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 5 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06961994
Start Date
April 29 2025
End Date
June 5 2025
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wonkwang University School of Medicine Hospital
Iksan, Jeollabuk-do, South Korea, 54538